
Scientists in London have developed a new tool that could lead to improved, personalised treatments for advanced breast cancer.
Researchers at the Institute of Cancer Research (ICR) have discovered the key features of B cells which make them successful at targeting tumours - including when cancer has spread to a different part of the body.